title: Relationship of adipokines and non-esterified fatty acid to the insulin resistance in non-diabetic individuals.
abstract: BACKGROUND
  Altered secretion of adipokines and non-esterified fatty acid (NEFA) seems to play a pivotal role in the abdominal obesity-related insulin resistance (IR).
  
  
  OBJECTIVE
  To determine semi-quantitatively the impact of serum NEFA, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), leptin, adiponectin, and resistin levels on IR measured by homeostasis model assessment (HOMA-IR). MATERIAL/SUBJECTS: Seventy-four Caucasian subjects forming 3 age-, and sex-matched groups were included into the study [Group 1 and 2: non-diabetic obese patients, no.= 25, body mass index (BMI): 28-39.9 kg/m(2), no.=25, BMI≥40 kg/m(2), respectively, and Group 3: 24 healthy, normal weight control subjects].
  
  
  METHODS
  Serum levels of NEFA and adipokines as well as other metabolic variables including HOMA-IR were measured.
  
  
  RESULTS
  HOMA-IR was associated positively with BMI, waist circumference, serum NEFA, leptin, IL-6, and TNF-α levels, negatively with adiponectin, with no significant relation to resistin. In multiple regression analyses, of these factors leptin was a strong, IL-6 and adiponectin were weak independent predictors of HOMA-IR, while the others were not significant determinants of HOMA-IR. However, even together, they explained only 35-36% of variance of HOMAIR.
  
  
  CONCLUSIONS
  Although IR has associations with many of the investigated parameters, of these, only serum level of leptin, and in lesser degree IL-6 and adiponectin are independent determinants of the severity of IR. Moreover, even together they explain only a minority of variance IR.
authors.affiliation: Institute of Laboratory Medicine, School of Medicine, University of Pécs, Pécs, Hungary.
authors.forename: A
authors.initials: A
authors.lastname: Peti
authors.forename: A
authors.initials: A
authors.lastname: Juhasz
authors.forename: P
authors.initials: P
authors.lastname: Kenyeres
authors.forename: Z
authors.initials: Z
authors.lastname: Varga
authors.forename: I
authors.initials: I
authors.lastname: Seres
authors.forename: G L
authors.initials: GL
authors.lastname: Kovacs
authors.forename: G
authors.initials: G
authors.lastname: Paragh
authors.forename: L
authors.initials: L
authors.lastname: Bajnok
mesh_terms: D054392:Adipokines / Q000032:analysis / Q000097:blood*; D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003920:Diabetes Mellitus / Q000097:blood / Q000378:metabolism; D004951:Esterification; D005227:Fatty Acids / Q000032:analysis / Q000097:blood*; D005260:Female; D006262:Health; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D055815:Young Adult
chemical_list: D054392:Adipokines; D005227:Fatty Acids
references.citation: J Clin Endocrinol Metab. 2007 Nov;92(11):4306-12
references.pmid: 17726077
references.citation: J Appl Physiol (1985). 2007 Feb;102(2):820; author reply 825
references.pmid: 17284658
references.citation: Eur J Clin Invest. 2008 Jan;38(1):71-2
references.pmid: 18173555
references.citation: Lancet. 2005 Sep 24-30;366(9491):1059-62
references.pmid: 16182882
references.citation: Acta Physiol (Oxf). 2008 Jan;192(1):37-48
references.pmid: 18171428
references.citation: Clin Endocrinol (Oxf). 2007 Nov;67(5):796-800
references.pmid: 17634078
references.citation: Horm Metab Res. 2007 Oct;39(10):764-8
references.pmid: 17952841
references.citation: Eur J Endocrinol. 2003 Mar;148(3):343-50
references.pmid: 12611616
references.citation: Eur J Endocrinol. 2002 Aug;147(2):173-80
references.pmid: 12153737
references.citation: Diabetes Care. 2007 Feb;30(2):286-91
references.pmid: 17259496
references.citation: J Clin Endocrinol Metab. 2003 Nov;88(11):5452-5
references.pmid: 14602788
references.citation: Diabetologia. 2003 Apr;46(4):459-69
references.pmid: 12687327
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: J Surg Res. 2005 Jun 1;126(1):121-9
references.pmid: 15916985
references.citation: J Clin Invest. 2003 Jan;111(2):225-30
references.pmid: 12531878
references.citation: Diabetes Care. 2000 Jan;23(1):57-63
references.pmid: 10857969
references.citation: Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83
references.pmid: 10092513
references.citation: Circulation. 2005 Feb 22;111(7):932-9
references.pmid: 15710760
references.citation: Clin Sci (Lond). 2002 Aug;103(2):137-42
references.pmid: 12149104
references.citation: J Clin Invest. 2002 May;109(10):1345-50
references.pmid: 12021250
references.citation: Obes Res. 2003 Aug;11(8):997-1001
references.pmid: 12917505
references.citation: Metabolism. 2007 Sep;56(9):1216-20
references.pmid: 17697864
references.citation: Eur J Endocrinol. 2003 Oct;149(4):331-5
references.pmid: 14514348
references.citation: Exp Clin Endocrinol Diabetes. 2005 Feb;113(2):67-79
references.pmid: 15772897
references.citation: J Clin Endocrinol Metab. 2003 Oct;88(10):4848-56
references.pmid: 14557464
references.citation: J Clin Endocrinol Metab. 2001 May;86(5):1930-5
references.pmid: 11344187
references.citation: Horm Metab Res. 2007 Oct;39(10):707-9
references.pmid: 17952830
references.citation: Ann Intern Med. 1999 Apr 20;130(8):671-80
references.pmid: 10215564
references.citation: J Clin Endocrinol Metab. 2008 Jul;93(7):2786-9
references.pmid: 18430770
references.citation: Curr Opin Clin Nutr Metab Care. 2002 Jul;5(4):377-83
references.pmid: 12107372
references.citation: Obes Rev. 2008 Jan;9(1):20-9
references.pmid: 17956545
references.citation: Lancet. 2005 Nov 5;366(9497):1640-9
references.pmid: 16271645
references.citation: J Lipid Res. 2006 Aug;47(8):1643-50
references.pmid: 16685078
references.citation: Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1595-9
references.pmid: 10845877
references.citation: Nat Med. 2001 Aug;7(8):941-6
references.pmid: 11479627
references.citation: Metabolism. 2005 Apr;54(4):471-5
references.pmid: 15798953